Related references
Note: Only part of the references are listed.Immunogenicity of Three Different Influenza Vaccines against Homologous and Heterologous Strains in Nursing Home Elderly Residents
Vincenzo Baldo et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2010)
H1N1: Can a Pandemic Cycle Be Broken?
Ethan C. Settembre et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Cross-Neutralization of 1918 and 2009 Influenza Viruses: Role of Glycans in Viral Evolution and Vaccine Design
Chih-Jen Wei et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus
Surender Khurana et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Seasonal Influenza Vaccine Provides Priming For A/H1N1 Immunization
Giuseppe Del Giudice et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling
Felix Geeraedts et al.
PLOS PATHOGENS (2008)
Vaxfectin™-formulated influenza DNA vaccines encoding NP and M2 viral proteins protect mice against lethal viral challenge
Gretchen S. Jimenez et al.
HUMAN VACCINES (2007)
CD4 T cell-mediated protection from lethal influenza: Perforin and antibody-mediated mechanisms a one-two punch
Deborah M. Brown et al.
JOURNAL OF IMMUNOLOGY (2006)
Share Paper
